本文關(guān)鍵詞：借鑒電子通信行業(yè)經(jīng)驗探討制藥行業(yè)專利標準化的實施路徑　出處：《中國藥房》2017年13期 　論文類型：期刊論文

  更多相關(guān)文章： 制藥行業(yè) 電子通信行業(yè) 專利標準化 實施路徑

【摘要】：目的:為制定制藥行業(yè)專利標準化實施路徑提供參考。方法:針對制藥行業(yè)專利標準化尚處于探索階段、缺乏可行經(jīng)驗的現(xiàn)狀,借鑒電子通信行業(yè)中專利領(lǐng)先于標準制定、權(quán)威組織幫助實施專利標準化、行業(yè)聯(lián)盟推動專利標準化發(fā)展等經(jīng)驗,結(jié)合標準的發(fā)展周期,嘗試制定出符合制藥行業(yè)特點的專利標準化實施路徑。結(jié)果與結(jié)論:制藥行業(yè)的專利標準化實施路徑分為標準形成、推廣、升級階段,各階段的主要路徑分別為由專利開始至藥品注冊標準正式形成、以國家食品藥品監(jiān)督管理總局的政策法規(guī)為導(dǎo)向通過藥品仿制進行標準推廣、通過專利替換來升級藥品標準。
[Abstract]:Objective: to provide a reference for the implementation of patent standardization in pharmaceutical industry. Methods: the current situation of patent standardization in pharmaceutical industry is still in the exploratory stage and lack of feasible experience. Draw lessons from the electronic communication industry patent ahead of the standard setting, authoritative organizations to help implement patent standardization, industry alliance to promote the development of patent standardization and other experience, combined with the standard development cycle. Results and conclusions: the implementation path of patent standardization in pharmaceutical industry can be divided into the stages of standard formation, promotion and upgrading. The main paths of each stage are from the beginning of patent to the formal formation of drug registration standards, and the national food and drug administration policies and regulations are used to promote the standards through drug imitation. Upgrade drug standards through patent replacement.
【作者單位】： 蘭州大學(xué)藥學(xué)院;蘭州大學(xué)生物醫(yī)藥知識產(chǎn)權(quán)研究中心;
【基金】：工業(yè)和信息化部知識產(chǎn)權(quán)推進計劃(No.2014020001)
【分類號】：R95
【正文快照】： 在技術(shù)密集型的高新技術(shù)行業(yè)中,技術(shù)成果的轉(zhuǎn)化路徑可總結(jié)為“技術(shù)專利化,專利標準化,標準許可化”[1]。其中,“技術(shù)專利化”是基礎(chǔ),即將技術(shù)創(chuàng)新成果通過專利申請的方式進行保護;“專利標準化”是過程,指將專利技術(shù)嵌入標準;“標準許可化”是目的,即對嵌入標準的專利進行許可，

本文編號：1419782